Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00246896 · ClinicalTrials.gov registry record · NA

Care Management for Patients With Alzheimer Disease and Their Family Caregivers

A NA study of Dementia and Alzheimers Disease, sponsored by Agency for Healthcare Research and Quality (AHRQ).

Completed
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT00246896: Completed NA study of Dementia and Alzheimers Disease, sponsored by Agency for Healthcare Research and Quality (AHRQ).

NCT00246896 is a NA study of Dementia and Alzheimers Disease that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 220 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00246896, a NA study of Dementia and Alzheimers Disease, has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).

COMPLETED
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

This is a clinical trial to test the effectiveness of current guideline for the care of older adults with Alzheimer's disease. The study focuses on the primary care setting using a nurse care manager to facilitate guideline-level care. We are hypothesizing that patients who receive guideline-level care will have fewer behavioral problems than those who receive the usual care provided in primary care settings

Interventions

  • BEHAVIORAL care management

Study Locations (1)

Indiana

  • Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2001-08
Est. Completion 2005-08
Phase NA

What the finished NCT00246896 record still lists

NCT00246896 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which care management is the first listed.

NCT00246896 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT00246896 about?

NCT00246896 is a clinical study titled "Care Management for Patients With Alzheimer Disease and Their Family Caregivers". This is a clinical trial to test the effectiveness of current guideline for the care of older adults with Alzheimer's disease. The study focuses on the primary care setting using a nurse care manager to facilitate guideline-level care. We are hypothesizing that patients who receive guideline-level c...

What is the current status of trial NCT00246896?

This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2001-08. Estimated completion is 2005-08.

What conditions does trial NCT00246896 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease.

What interventions are being tested in trial NCT00246896?

The interventions under investigation include: care management (BEHAVIORAL).

Who is sponsoring clinical trial NCT00246896?

This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00246896 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00246896's enrollment target sits among peer trials

220 85th of 199 higher than 115 of 199 other Dementia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00246896, the US trial registry maintained by the National Library of Medicine. NCT00246896 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.